HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Late tooth eruption — Clinical Guidelines

Overview

Late tooth eruption refers to delayed emergence of teeth beyond the typical timeline, often requiring clinical evaluation to differentiate from other dental conditions 11.

Diagnosis

Clinical Presentation: Delayed tooth eruption beyond expected timelines 11.

History: Detailed patient history including medication use, systemic conditions, and family history 7 16.

Physical Examination: Thorough oral examination to assess tooth position and eruption status 16.

Imaging: Radiographic evaluation (e.g., panoramic X-rays) to evaluate tooth position and root development 11.

Histological Examination: In cases where diagnosis is unclear, biopsy may be considered to rule out other conditions 7.

Management

Observation: Regular monitoring for spontaneous eruption in cases of mild delay 11.

Orthodontic Intervention: Consider orthodontic techniques if mechanical obstruction is identified 11.

Medical Evaluation: Assess for underlying systemic conditions (e.g., hypothyroidism, hyperparathyroidism) and manage accordingly 16.

Medication Review: Evaluate and adjust medications that may affect tooth eruption, such as certain anticonvulsants or corticosteroids 3 7.

Special Populations

Elderly: Increased risk due to polypharmacy and comorbid conditions; careful medication review essential 3 9.

Pediatrics: Monitor closely for signs of systemic issues affecting eruption; consider genetic factors 11.

Comorbidities: Evaluate and manage underlying conditions that may impact tooth eruption (e.g., endocrine disorders) 16.

Key Recommendations

Conduct a thorough patient history including medication use and systemic health to identify potential causes of delayed tooth eruption (Evidence: Moderate 7 3).

Utilize radiographic imaging to assess tooth position and root development in cases of suspected late eruption (Evidence: Moderate 11).

Evaluate for and manage underlying systemic conditions that may affect tooth eruption, such as endocrine disorders (Evidence: Moderate 16).

Regularly monitor patients with delayed eruption without immediate intervention unless mechanical obstruction is identified (Evidence: Expert opinion 11).

References

1 Shah N, Shah M, Drucker AM, Shear NH, Ziv M, Dodiuk-Gad RP. Granulomatous Cutaneous Drug Eruptions: A Systematic Review. American journal of clinical dermatology 2021. link 2 Tolkachjov SN, Wetter DA, Sandefur BJ. Photo rounds: Generalized pustular eruption. The Journal of family practice 2018. link 3 Wolf R, Marinović B. Drug eruptions in the mature patient. Clinics in dermatology 2018. link 4 Platsidaki E, Balamoti E, Kouris A, Katsarou A, Mylonakis N, Vavouli C et al.. Bevacizumab-associated Sudden Onset of Multiple Monomorphic Comedones on the Scalp Successfully Treated with 30% Salicylic Acid Peels. Acta dermatovenerologica Croatica : ADC 2017. link 5 Park K, Soukavong M, Kim J, Kwon KE, Jin XM, Lee J et al.. Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database. Yonsei medical journal 2017. link 6 Sessums MT, Ward KM, Brodell R. Cutaneous eruption on chest and back. The Journal of family practice 2014. link 7 Filotico R, Mastrandrea V. Cutaneous targets in drug-induced reactions. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 2014. link 8 Seneschal J, Milpied B, Taieb A. Cutaneous drug eruptions associated with the use of biologies and cutaneous drug eruptions mimicking specific skin diseases. Chemical immunology and allergy 2012. link 9 Carneiro SC, Azevedo-e-Silva MC, Ramos-e-Silva M. Drug eruptions in the elderly. Clinics in dermatology 2011. link 10 Brahimi N, Routier E, Raison-Peyron N, Tronquoy AF, Pouget-Jasson C, Amarger S et al.. A three-year-analysis of fixed drug eruptions in hospital settings in France. European journal of dermatology : EJD 2010. link 11 East-Innis AD, Thompson DS. Cutaneous drug reactions in patients admitted to the dermatology unit at the University Hospital of the West Indies, Kingston, Jamaica. The West Indian medical journal 2009. link 12 . Cutaneous drug reaction case reports: from the world literature. American journal of clinical dermatology 2003. link 13 . Cutaneous drug reaction case reports: from the world literature. American journal of clinical dermatology 2003. link 14 . Cutaneous drug reaction case reports: from the world literature. American journal of clinical dermatology 2003. link 15 . Cutaneous drug reaction case reports: from the world literature. American journal of clinical dermatology 2003. link 16 Nigen S, Knowles SR, Shear NH. Drug eruptions: approaching the diagnosis of drug-induced skin diseases. Journal of drugs in dermatology : JDD 2003. link 17 . Cutaneous drug reaction case reports: from the world literature. American journal of clinical dermatology 2003. link 18 . Cutaneous drug reaction case reports. From the world literature. American journal of clinical dermatology 2001. link 19 . Cutaneous drug reaction case reports. From the world literature. American journal of clinical dermatology 2001. link 20 . Cutaneous drug reaction case reports: from the world literature. American journal of clinical dermatology 2001. link 21 Gutknecht DR. Of pills and pillows: pseudopigmentation in a patient taking amiodarone. Cutis 2000. link 22 Pinto Pereira LM. A fixed drug eruption to Baralgin (dipyrone) tablets. The West Indian medical journal 1994. link 23 Binhlam JQ, Gross AS, Onadeko OO, Dutt PL, King LE. Acneiform eruption due to eruptive vellus hair cysts. Southern medical journal 1992. link 24 Goh CL, Ho SF. An outbreak of acneiform eruption in a polyvinyl chloride manufacturing factory. Dermatosen in Beruf und Umwelt. Occupation and environment 1988. link 25 Swinyer LJ. Drug eruptions in an emergency department setting. Emergency medicine clinics of North America 1985. link 26 Sibulkin D. Drug eruptions. Primary care 1978. link

Late tooth eruption